Castration-resistant prostate cancer: targeted therapies and individualized treatment
about
Improvement of a predictive model of castration-resistant prostate cancer: functional genetic variants in TGFβ1 signaling pathway modulation.Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer.Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer.Current management of prostate cancer: dilemmas and trialsMolecular signatures in urologic tumors.Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer.A multi-target protein of hTERTR-FAM96A presents significant anticancer potent in the treatment of hepatocellular carcinoma.mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review.Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cellsPreclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma.Combination therapy of hTERTR and FAM96A for hepatocellular carcinoma through enhancing apoptosis sensitivity.
P2860
Q34951665-C733205B-6457-4057-8725-E8014601C61CQ36329301-BC659444-316E-4D33-8360-882618655BFCQ36585622-D8D9A6F5-1EE7-44FA-82CF-8E6105410BABQ37102535-548BA1B5-CE69-4EC4-BE81-32670EA457C1Q37225156-7010A058-0FAF-4CE9-B724-0237320D1826Q38407976-376BD727-5718-443D-9256-150F56561434Q38706044-D044278C-169B-4982-B3D0-FB0A035703FCQ38922287-498731A1-AF65-48F7-BB8F-227491D0BAADQ39001625-4D266E86-78AA-4D40-B2BF-075DD5D64754Q39150333-4258DE6F-4320-4DE6-8CBE-7E3317DF3DCEQ41623726-82F0B1A8-71F2-4E78-89A2-ECA7DFACC332Q49215955-365ED28B-0614-4F18-8CD5-DAE54DEF8B52
P2860
Castration-resistant prostate cancer: targeted therapies and individualized treatment
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Castration-resistant prostate cancer: targeted therapies and individualized treatment
@en
Castration-resistant prostate cancer: targeted therapies and individualized treatment.
@nl
type
label
Castration-resistant prostate cancer: targeted therapies and individualized treatment
@en
Castration-resistant prostate cancer: targeted therapies and individualized treatment.
@nl
prefLabel
Castration-resistant prostate cancer: targeted therapies and individualized treatment
@en
Castration-resistant prostate cancer: targeted therapies and individualized treatment.
@nl
P2860
P1433
P1476
Castration-resistant prostate cancer: targeted therapies and individualized treatment
@en
P2093
Charles J Ryan
Rahul Aggarwal
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0216
P577
2011-02-21T00:00:00Z